Svenska Handelsbanken Ab (Publ) Eli Lilly & CO Transaction History

Svenska Handelsbanken Ab (Publ)

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 27, 2021	SELL	$164.32 - $212.72 $2.65 Million - $3.42 Million	-16,100 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$130.46 - $172.63 $2.1 Million - $2.78 Million	16,100 New	16,100 $2.72 Million
Q3 2020 Nov 10, 2020	SELL	$146.22 - $169.13 $2.35 Million - $2.72 Million	-16,100 Closed	0 $0
Q2 2020 Jul 21, 2020	SELL	$136.42 - $164.18 $709,383 - $853,736	-5,200 Reduced 24.41%	16,100 $2.64 Million
Q4 2019 Jan 28, 2020	BUY	$106.92 - $132.43 $245,916 - $304,589	2,300 Added 12.11%	21,300 $2.8 Million
Q3 2019 Oct 31, 2019	BUY	$106.79 - $116.16 $1.23 Million - $1.34 Million	11,500 Added 153.33%	19,000 $2.13 Million
Q2 2019 Jul 30, 2019	BUY	$110.79 - $129.32 $830,925 - $969,900	7,500 New	7,500 $831,000

3,869

751M

6.34M

7.97M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $847B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Svenska Handelsbanken Ab (Publ), based on Form 13F filings with the SEC.

Stay updated on Svenska Handelsbanken Ab (Publ) with notifications on news.